Chinese materia medica(CMM) 第1页

Application of PK-PD modeling in pharmacokinetics of Chinese materia medics Principles of chemomic release/dissolution kinetics for Chinese materia medica in conventional dosage forms or drug delivery systems Powder direct tableting technology and its key issue used in Chinese materia medica Good agricultural practice (GAP) of Chinese materia medica (CMM) for ten years：achievements, problems and proposals Comparison and thinking on tracing historical source and contemporary understanding of Chinese materia medica toxicity Application of ultrahigh pressure technology in extracting active component from Chinese materia medica Support vector machine and Chinese materia medica research Application of pharmacokinetics in secondary development of classical prescription on Chinese materia medica Advances in studies on Chinese materia medica effect on ion channels of myocardial cell Reflection on standardized data of original plant species for Chinese materia medica Advances in studies on fingerprints of Chinese materia medica Advances in studies on active components modulating tissue factor in Chinese materia medics Advances in studies on ceramic membrane applied in Chinese materia medics refining Key problems on development of classic Chinese materia medica recipe Application of film coating in moisture prevention of Chinese materia medica Survey on active components in plant with antitumor activity by epigenetic modulation Probing on numeralization problem of Chinese materia medica fingerprint Application of several nanometer drug delivery systems to improving ADME/Tox of Chinese materia medica Thinking mode and practice of study on newly-developed drug of Chinese materia medica Effect of aldosterone on cardiac ventricular remodeling and intervention of Chinese materia medica Establishment of immunological database and study on immunological regularity of Chinese materia medica Burgeoning disciplines in biomedicine and their application to modernization of Chinese materia medica --studies on novel multicomponent drugs Analysis of patent protection of Chinese materia medica in USA Problems and countermeasure of screening studies on estrogen receptor modulators in Chinese materia medica Problems and solutions during development of sustained-or controlled-release drug delivery systems of Chinese materia medica